On July 12, 2026, researchers from the Weizmann Institute of Science unveiled a groundbreaking study where they engineered a plant to produce five different psychedelic substances simultaneously. This remarkable achievement could revolutionize the way we access and utilize psychedelics for various applications, including mental health treatments.
Engineering Psychedelics: The Study's Foundation
The research focused on the biosynthetic pathways of DMT, a well-known psychedelic compound found in various plants. The team, led by Dr. Paula (Shirley) Berman, successfully mapped the complete DMT production pathway in the model plant Nicotiana benthamiana, enabling it to generate DMT within days.
Utilizing advanced metabolic engineering techniques, the researchers identified key genes and enzymes necessary for synthesizing DMT. They inserted these genes into the model plant, effectively teaching it how to produce the compound.
Five Psychedelics from Three Kingdoms of Life
The five psychedelics produced in this study include:
- DMT from the plant kingdom
- Psilocybin and psilocin from the fungal kingdom
- Bufotenin and 5-MeO-DMT from the animal kingdom
Each of these compounds has a rich history in cultural and spiritual practices, from ayahuasca rituals in the Amazon to magic mushrooms used by the Aztecs. The successful combination of these diverse compounds in a single organism showcases the potential for innovative applications in both science and therapy.
Challenges and Innovations in Production
Despite the initial success, the researchers faced challenges when attempting to produce all five compounds within the same plant. The activation of multiple biosynthetic pathways led to competition for the same starting materials, causing a bottleneck in production efficiency.
To address this, the team collaborated with experts in protein design to improve enzyme efficiency. By mutating a single amino acid in the enzyme responsible for producing 5-MeO-DMT, they achieved a staggering 40-fold increase in production.
This innovative approach not only enhances the efficiency of psychedelic production but also opens the door for the creation of novel compounds that do not naturally occur in plants.
🤖 This article was rewritten by Feed and Figures' editorial AI from a report originally published by Phys.org. Facts and quotes are preserved from the original; the rewrite focuses on clarity and structure. For the unedited original, see the source link below.
